Clinical diagnosis and therapy of mixed epithelial and stromal tumor of kidney

Su Shi-qiang,Zhang Qian,Liu Li-zhe,He Qun,Chen Yan,Yang Cui-xia,Liu Hong-jiu,Pang Shu-jian

DOI: https://doi.org/10.3969/j.issn.1005-8982.2016.22.016

2016-01-01

Abstract:Objective To analyze 13 cases with mixed epithelial and stromal tumor of the kidney (MESTK) and to approach the treatment. Methods The clinical data of 13 MESTK patients (2 males and 11 females, aged 15-57 years) treated in our department from January 2003 to July 2015 were retrospectively analyzed. Medical imaging manifested ulti-cystic lesions without mural nodules. All the patients underwent surgical resection. Results Among the 13 MESTK patients, 4 accepted radical nephrectomy including 1 receiving embolization of renal artery before operation, 3 accepted retroperitoneal laparoscopic radical nephrectomy, 4 accepted retroperitoneal laparoscopic partial nephrectomy, 2 accepted laparoscopic partial nephrectomy. All the patients were successfully followed up for 5 to 159 months. One of them had recurrence 24 months after operation and received operation again, and is still followed up. The remaining cases had no recurrence or metastasis. Conclusions MESTK is an unusual tumor with high misdiagnosis because it has no specific clinical manifestations. MESTK should be taken into consideration when ulti-cystic lesions have no mural nodules but delayed enhancement. Intraoperative frozen section is helpful to distinguish benign from malignant tumors, Complete resection of the tumor is the treatment principle, nephron-sparing surgery is safe and effective. In addition, regular follow-up is necessary for the cases with recurrence and malignant potential.